Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-methyl-n-(endo-9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxamide
2. 1h-indazole-3-carboxamide, 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl
3. 1h-indazole-3-carboxamide, 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, Endo-
4. Brl 43694
5. Brl 43694a
6. Brl-43694
7. Brl-43694a
8. Brl43694
9. Brl43694a
10. Granisetron
11. Granisetron Hydrochloride
12. Granisetron Monohydrochloride
13. Hydrochloride, Granisetron
14. Kytril
15. Monohydrochloride, Granisetron
1. Granisetron
2. 109889-09-0
3. Exo-granisetron (granisetron Impurity F)
4. 1364914-39-5
5. 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide
6. Granisetronum [inn-latin]
7. 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1h-indazole-3-carboxamide
8. Brl 43694
9. Granisetron-d3
10. Granisetron Base
11. [3h]-granisetron
12. Ly-278584
13. [3h]granisetron
14. Apf-530
15. 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1h-indazole-3-carboxamide
16. 1-methyl-n-{9-methyl-9-azabicyclo[3.3.1]nonan-3-yl}-1h-indazole-3-carboxamide
17. [3h]-brl-43694
18. Schembl445223
19. Chembl289469
20. Chembl519643
21. Gtpl2292
22. 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide
23. Dtxsid50861188
24. Chebi:184693
25. Bcp10022
26. Ex-a1291
27. Hy-b0071
28. Bbl036319
29. Bdbm50000483
30. Pdsp1_001266
31. Pdsp2_001250
32. Stl483411
33. Akos015895362
34. Ab07494
35. Cs-1509
36. Sdccgsbi-0633801.p001
37. Ncgc00186041-01
38. Ncgc00186041-09
39. Ls-14665
40. Ft-0626805
41. Ab01274752-01
42. Ab01274752_02
43. Ab01274752_03
44. Aa-504/10505045
45. L000281
46. 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]nonan-7-yl)indazole-3-carboxamide
47. 1-methyl-1h-indazole-3-carboxylic Acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide
48. 1-methyl-1h-indazole-3-carboxylic Acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide
49. 1-methyl-n-((1s,5r)-9-methyl-9-aza-bicyclo[3.3.1]nonan-3-yl)-1h-indazole-3-carboxamide
50. N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1-methyl-1h-indazole-3-carboxamide
51. (brl 43694)1-methyl-1h-indazole-3-carboxylic Acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide
52. (granisetron)1-methyl-1h-indazole-3-carboxylic Acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide
53. 1-methyl-1h-indazole-3-carboxylic Acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide(brl 43694)
54. 1-methyl-1h-indazole-3-carboxylic Acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide(granisetron)
55. 2-(9-methyl-3,9-diaza-bicyclo[3.3.1]non-3-yl)-1-(1-methyl-1h-indol-3-yl)-ethanone(granisetron)
Molecular Weight | 312.4 g/mol |
---|---|
Molecular Formula | C18H24N4O |
XLogP3 | 2.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 312.19501140 g/mol |
Monoisotopic Mass | 312.19501140 g/mol |
Topological Polar Surface Area | 50.2 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 442 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Prevention of nausea and vomiting in patients receiving moderately or highly emetogenic chemotherapy, with or without cisplatin, for up to five consecutive days.
Sancuso may be used in patients receiving their first chemotherapy regimen or in patients who have previously received chemotherapy.
Serotonin 5-HT3 Receptor Antagonists
Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
A04AA02
A - Alimentary tract and metabolism
A04 - Antiemetics and antinauseants
A04A - Antiemetics and antinauseants
A04AA - Serotonin (5ht3) antagonists
A04AA02 - Granisetron
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Endo-3-amine-9-methyl-9-azabicyclo[3,3,1]nonane
CAS Number : 76272-56-5
End Use API : Granisetron
About The Company : We specialize in the supply of API and API related intermediates and services. A significant part of our business comes from the process/production development ...
1-Methylindazole-3-carboxylic acid
CAS Number : 50890-83-0
End Use API : Granisetron
About The Company : We specialize in the supply of API and API related intermediates and services. A significant part of our business comes from the process/production development ...
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2025-01-22
US Patent Number : 7608282
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22198
Patent Use Code : U-1011
Delist Requested :
Patent Use Description : USE OF GRANISETRON TRA...
Patent Expiration Date : 2025-01-22
Patent Expiration Date : 2024-09-28
US Patent Number : 10357570
Drug Substance Claim :
Drug Product Claim :
Application Number : 22445
Patent Use Code : U-2253
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-09-28
Patent Expiration Date : 2024-09-28
US Patent Number : 8252304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22445
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-09-28
Patent Expiration Date : 2024-09-28
US Patent Number : 8715710
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22445
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-09-28
Patent Expiration Date : 2024-09-28
US Patent Number : 9913910
Drug Substance Claim :
Drug Product Claim :
Application Number : 22445
Patent Use Code : U-2253
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-09-28
Patent Expiration Date : 2024-09-28
US Patent Number : 8252305
Drug Substance Claim :
Drug Product Claim :
Application Number : 22445
Patent Use Code : U-1891
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-09-28
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?